In breast cancer, although the incidence of amplification or mutation of MDM2 is relatively low, increased abundance of MDM2 protein occurs in ~ 38% of all breast cancers and is more frequent among ER-positive than in ER-negative tumours [6, 11]. This evidence concerns the gene MDM2 and neoplasm.